Your browser doesn't support javascript.
loading
Complement in human disease: approved and up-and-coming therapeutics.
West, Erin E; Woodruff, Trent; Fremeaux-Bacchi, Veronique; Kemper, Claudia.
Afiliación
  • West EE; Complement and Inflammation Research Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
  • Woodruff T; School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia.
  • Fremeaux-Bacchi V; Inserm UMRS1138, Centre de Recherche des Cordeliers, Inflammation, Complement, and Cancer Team, Paris, France; Department of Immunology, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Kemper C; Complement and Inflammation Research Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: claudia.kemper@nih.gov.
Lancet ; 403(10424): 392-405, 2024 Jan 27.
Article en En | MEDLINE | ID: mdl-37979593

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Hemoglobinuria Paroxística Límite: Humans Idioma: En Revista: Lancet Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Hemoglobinuria Paroxística Límite: Humans Idioma: En Revista: Lancet Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos